AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 1-25/70
IMMUNOLOGICAL AND FUNCTIONAL ANALYSES OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
Authors: MAGDOLEN V ALBRECHT S KOTZSCH M HALLER C BURGLE M JACOB U GROSSER M KESSLER H GRAEFF H MULLER M SCHMITT M LUTHER T
Citation: V. Magdolen et al., IMMUNOLOGICAL AND FUNCTIONAL ANALYSES OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR, Biological chemistry, 379(2), 1998, pp. 157-165
THE INFLUENCE OF UPPER ABDOMINAL-SURGERY ON PERIOPERATIVE MORBIDITY AND MORTALITY IN PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-III AND FIGO-IV
Authors: KUHN W FLORACK G RODER J SCHMALFELDT B PACHE L RUST M ULM K SPATHE K JANICKE F SIEWERT JR GRAEFF H
Citation: W. Kuhn et al., THE INFLUENCE OF UPPER ABDOMINAL-SURGERY ON PERIOPERATIVE MORBIDITY AND MORTALITY IN PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-III AND FIGO-IV, International journal of gynecological cancer, 8(1), 1998, pp. 56-63
MULTIFUNCTIONAL POTENTIAL OF THE PLASMINOGEN ACTIVATION SYSTEM IN TUMOR INVASION AND METASTASIS (REVIEW)
Authors: REUNING U MAGDOLEN V WILHELM O FISCHER K LUTZ V GRAEFF H SCHMITT M
Citation: U. Reuning et al., MULTIFUNCTIONAL POTENTIAL OF THE PLASMINOGEN ACTIVATION SYSTEM IN TUMOR INVASION AND METASTASIS (REVIEW), International journal of oncology, 13(5), 1998, pp. 893-906
THROMBOMODULIN, A RECEPTOR FOR THE SERINE-PROTEASE THROMBIN, IS DECREASED IN PRIMARY TUMORS AND METASTASES BUT INCREASED IN ASCITIC FLUIDS OF PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-IIIC
Authors: WILHELM S SCHMITT M PARKINSON J KUHN W GRAEFF H WILHELM OG
Citation: S. Wilhelm et al., THROMBOMODULIN, A RECEPTOR FOR THE SERINE-PROTEASE THROMBIN, IS DECREASED IN PRIMARY TUMORS AND METASTASES BUT INCREASED IN ASCITIC FLUIDS OF PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-IIIC, International journal of oncology, 13(4), 1998, pp. 645-651
DISEASE-ADAPTED RELAPSE THERAPY FOR OVARIAN-CANCER - RESULTS OF A PROSPECTIVE-STUDY
Authors: KUHN W SCHMALFELDT B PACHE L SPATHE K ULM K RENZIEHAUSEN K NOSCHEL H CANZLER E RICHTER B KRONER M TILCH G JANICKE F GRAEFF H
Citation: W. Kuhn et al., DISEASE-ADAPTED RELAPSE THERAPY FOR OVARIAN-CANCER - RESULTS OF A PROSPECTIVE-STUDY, International journal of oncology, 13(1), 1998, pp. 57-63
LACK OF CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND THE EFFECT OFDOSE-INTENSIFICATION OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS
Authors: THOMSSEN C UNTCH M KONECNY G LEBEAU A DETTMAR P SATTLER D KUHN W KAHLERT S HEPP H GRAEFF H JANICKE F
Citation: C. Thomssen et al., LACK OF CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND THE EFFECT OFDOSE-INTENSIFICATION OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 132-132
RANDOMIZED ADJUVANT TRIAL COMPARING 2 DOSE INTENSITIES OF EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) IN HIGH-RISK BREAST-CANCER
Authors: KONECNY G THOMSSEN C UNTCH M KAHLERT S KUHN W SATTLER D PICHE E LEBEAU A DETTMAR P GRAEFF H JANICKE F
Citation: G. Konecny et al., RANDOMIZED ADJUVANT TRIAL COMPARING 2 DOSE INTENSITIES OF EPIRUBICIN AND CYCLOPHOSPHAMIDE (EC) IN HIGH-RISK BREAST-CANCER, European journal of cancer, 34, 1998, pp. 164-164
TUMORBIOLOGICAL FACTORS (UPA, PAI-1) AS SELECTION CRITERIA FOR ADJUVANT CHEMOTHERAPY IN AXILLARY NODE-NEGATIVE BREAST-CANCER PATIENTS
Authors: JANICKE F THOMSSEN C HARBECK N PRECHTL A BERGER U ULM K DETTMAR P PACHE L SCHMITT M GRAEFF H
Citation: F. Janicke et al., TUMORBIOLOGICAL FACTORS (UPA, PAI-1) AS SELECTION CRITERIA FOR ADJUVANT CHEMOTHERAPY IN AXILLARY NODE-NEGATIVE BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 45-45
UROKINASE RECEPTOR LOCALIZATION IN BREAST-CANCER AND BENIGN LESIONS ASSESSED BY IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY
Authors: HILDENBRAND R GLIENKE W MAGDOLEN V GRAEFF H STUTTE HJ SCHMITT M
Citation: R. Hildenbrand et al., UROKINASE RECEPTOR LOCALIZATION IN BREAST-CANCER AND BENIGN LESIONS ASSESSED BY IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMISTRY, HISTOCHEM C, 110(1), 1998, pp. 27-32
PLASMINOGEN-ACTIVATOR SYSTEM IN BREAST-CANCER TISSUE AND BLOOD - CLINICAL RELEVANCE AND METHODOLOGICAL CONSIDERATIONS
Authors: HARBECK N GRAEFF H HOFLER H BRUNNER N SCHMITT M
Citation: N. Harbeck et al., PLASMINOGEN-ACTIVATOR SYSTEM IN BREAST-CANCER TISSUE AND BLOOD - CLINICAL RELEVANCE AND METHODOLOGICAL CONSIDERATIONS, Journal of tumor marker oncology, 13(4), 1998, pp. 19-35
IDENTIFICATION OF LOW-RISK NODE-NEGATIVE BREAST-CANCER PATIENTS BY TUMOR BIOLOGICAL FACTORS PAI-1 AND CATHEPSIN-L
Authors: THOMSSEN C OPPELT P JANICKE F ULM K HARBECK N HOFLER H KUHN W GRAEFF H SCHMITT M
Citation: C. Thomssen et al., IDENTIFICATION OF LOW-RISK NODE-NEGATIVE BREAST-CANCER PATIENTS BY TUMOR BIOLOGICAL FACTORS PAI-1 AND CATHEPSIN-L, Anticancer research, 18(3C), 1998, pp. 2173-2180
PROGNOSTIC IMPACT OF TUMOR BIOLOGICAL FACTORS ON SURVIVAL IN NODE-NEGATIVE BREAST-CANCER
Authors: HARBECK N DETTMAR P THOMSSEN C HENSELMANN B KUHN W ULM K JANICKE F HOFLER H GRAEFF H SCHMITT M
Citation: N. Harbeck et al., PROGNOSTIC IMPACT OF TUMOR BIOLOGICAL FACTORS ON SURVIVAL IN NODE-NEGATIVE BREAST-CANCER, Anticancer research, 18(3C), 1998, pp. 2187-2197
FDG PET EVALUATION OF GRANULAR-CELL TUMOR OF THE BREAST
Authors: HOESS C FREITAG K KOLBEN M ALLGAYER B LAEMMERSKARKE I NATHRATH BJ AVRIL N ROEMER W SCHWAIGER M GRAEFF H
Citation: C. Hoess et al., FDG PET EVALUATION OF GRANULAR-CELL TUMOR OF THE BREAST, The Journal of nuclear medicine, 39(8), 1998, pp. 1398-1401
THROMBOMODULIN MODULATES GROWTH OF TUMOR-CELLS INDEPENDENT OF ITS ANTICOAGULANT ACTIVITY
Authors: ZHANG YM WEILERGUETTLER H CHEN J WILHELM O DENG YH QIU F NAKAGAWA K KLEVESATH M WILHELM S BOHRER H NAKAGAWA M GRAEFF H MARTIN E STERN DM ROSENBERG RD ZIEGLER R NAWROTH PP
Citation: Ym. Zhang et al., THROMBOMODULIN MODULATES GROWTH OF TUMOR-CELLS INDEPENDENT OF ITS ANTICOAGULANT ACTIVITY, The Journal of clinical investigation, 101(7), 1998, pp. 1301-1309
CLINICAL RELEVANCE OF TUMOR INVASION AND PROLIFERATION FACTORS IN BREAST-CANCER
Authors: HARBECK N GRAEFF H HOFLER H JANICKE F SCHMITT M
Citation: N. Harbeck et al., CLINICAL RELEVANCE OF TUMOR INVASION AND PROLIFERATION FACTORS IN BREAST-CANCER, Geburtshilfe und Frauenheilkunde, 58(7), 1998, pp. 374-381
CAUSAL ATTRIBUTIONS FOR CANCER AND THE US E OF PSYCHOONCOLOGICAL SUPPORT BY BREAST-CANCER PATIENTS
Authors: LEIST R SCHANZER K GRIGELAT A JANICKE F GRAEFF H
Citation: R. Leist et al., CAUSAL ATTRIBUTIONS FOR CANCER AND THE US E OF PSYCHOONCOLOGICAL SUPPORT BY BREAST-CANCER PATIENTS, Geburtshilfe und Frauenheilkunde, 58(1), 1998, pp. 27-32
UROKINASE INDUCES PROLIFERATION OF HUMAN OVARIAN-CANCER CELLS - CHARACTERIZATION OF STRUCTURAL ELEMENTS REQUIRED FOR GROWTH-FACTOR FUNCTION
Authors: FISCHER K LUTZ V WILHELM O SCHMITT M GRAEFF H HEISS P NISHIGUCHI T HARBECK N KESSLER H LUTHER T MAGDOLEN V REUNING U
Citation: K. Fischer et al., UROKINASE INDUCES PROLIFERATION OF HUMAN OVARIAN-CANCER CELLS - CHARACTERIZATION OF STRUCTURAL ELEMENTS REQUIRED FOR GROWTH-FACTOR FUNCTION, FEBS letters, 438(1-2), 1998, pp. 101-105
INHIBITION OF THE INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR(UPA) WITH ITS RECEPTOR (UPAR) BY SYNTHETIC PEPTIDES
Authors: BURGLE M KOPPITZ M RIEMER C KESSLER H KONIG B WEIDLE UH KELLERMANN J LOTTSPEICH F GRAEFF H SCHMITT M GORETZKI L REUNING U WILHELM O MAGDOLEN V
Citation: M. Burgle et al., INHIBITION OF THE INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR(UPA) WITH ITS RECEPTOR (UPAR) BY SYNTHETIC PEPTIDES, Biological chemistry, 378(3-4), 1997, pp. 231-237
QUANTITATIVE ASSESSMENT OF INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR (CD87) BY USE OF A SOLID-PHASE UPA-LIGAND BINDING ASSAY
Authors: GORETZKI L BOGNACKI J KOPPITZ M RETTENBERGER P MAGDOLEN V CREUTZBURG S HAMMELBURGER J WEIDLE UH WILHELM O KESSLER H GRAEFF H SCHMITT M
Citation: L. Goretzki et al., QUANTITATIVE ASSESSMENT OF INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR (CD87) BY USE OF A SOLID-PHASE UPA-LIGAND BINDING ASSAY, Fibrinolysis & proteolysis, 11(1), 1997, pp. 11-19
OPTIMIZED DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS BY COMBINED B-MODEAND COLOR DOPPLER SONOGRAPHY
Authors: SCHELLING M GNIRS J BRAUN M BUSCH R MAURER S KUHN W SCHNEIDER KTM GRAEFF H
Citation: M. Schelling et al., OPTIMIZED DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS BY COMBINED B-MODEAND COLOR DOPPLER SONOGRAPHY, Ultrasound in obstetrics & gynecology, 10(1), 1997, pp. 48-53
DOSE-INTENSIFIED VERSUS STANDARD CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS - PRELIMINARY DATA OF A RANDOMIZED TRIAL
Authors: THOMSSEN C UNTCH M SCHILL E SATTLER D KONECNY G BAUERNFEIND P JANICKE F GRAEFF H
Citation: C. Thomssen et al., DOSE-INTENSIFIED VERSUS STANDARD CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER PATIENTS - PRELIMINARY DATA OF A RANDOMIZED TRIAL, European journal of cancer, 33, 1997, pp. 662-662
LONG-TERM PROGNOSTIC IMPACT OF PAI-1 IN PRIMARY BREAST-CANCER CONFIRMED BY 6-YEAR MEDIAN FOLLOW-UP
Authors: HARBECK N THOMSSEN C HENSELMANN B DETTMAR P PRECHTL A PACHE L KUHN W HOFLER H JANICKE F SCHMITT M GRAEFF H
Citation: N. Harbeck et al., LONG-TERM PROGNOSTIC IMPACT OF PAI-1 IN PRIMARY BREAST-CANCER CONFIRMED BY 6-YEAR MEDIAN FOLLOW-UP, European journal of cancer, 33, 1997, pp. 877-877
BREAST-CANCER PROGNOSTIC AND THERAPY-RELE VANT FACTORS - RESULTS OF ACONSENSUS CONFERENCE
Authors: GRAEFF H WILMANNS W JANICKE F SAUER H CLASSEN S
Citation: H. Graeff et al., BREAST-CANCER PROGNOSTIC AND THERAPY-RELE VANT FACTORS - RESULTS OF ACONSENSUS CONFERENCE, Onkologie, 20(5), 1997, pp. 426-429
POSITRON EMISSION TOMOGRAPHY FOR DIAGNOSIS OF BREAST-TUMORS
Authors: DOSE J AVRIL N GRAEFF H JANICKE F
Citation: J. Dose et al., POSITRON EMISSION TOMOGRAPHY FOR DIAGNOSIS OF BREAST-TUMORS, Onkologie, 20(3), 1997, pp. 190-195
THROMBOMODULIN MODULATES GROWTH OF TUMOR-CELLS INDEPENDENT OF ITS ANTICOAGULANT ACTIVITY
Authors: ZHANG Y WEILER H WILHELM O DENG Y QIU F NAKAGAWA K KLEVESATH M WILHELM S GRAEFF H BOHRER H MARTIN E STERN D ROSENBERG R ZIEGLER R NAWROTH P
Citation: Y. Zhang et al., THROMBOMODULIN MODULATES GROWTH OF TUMOR-CELLS INDEPENDENT OF ITS ANTICOAGULANT ACTIVITY, Thrombosis and haemostasis, 1997, pp. 2249-2249
Risultati: 1-25 | 26-50 | 51-70